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A significant percentage of susceptible 
dispensing doctors are being ‘sucked 
into’ a shady system where the punitive 
decks are stacked against them because 
gaps in the law allow organised 
pharmacy to offer ‘undue rewards’ with 
relative impunity.
They face stiff Health Professions 
Council (HPCSA) sanctions equal to the 
quantum of any kickbacks or ill-gotten 
gains plus 5% – but the pharmaceutical 
industry can drive a bus through 
gaps in the laws and regulations 
discouraging them. A pharmaceutical 
industry draft marketing code and a 
recently published code of conduct, 
although reportedly having ‘90% 
buy-in’, are simply not enough to 
significantly change shady practices that 
put profit above patient interests.
These were some of the broad themes 
to emerge at a 2-hour briefing and 
debate session organised by Qualicare, 
the Western Cape’s largest independent 
practitioners association and founder 
member of the South African Managed 
Care Co-operative, on 18 February.
The convenor, Dr Tony Behrman, 
warned his Cape Town audience of 
mainly pharmaceutical company 
directors and shareholders, that 
although the law was stacked against 
doctors, ‘if we’re taken down, we’ll 
request assistance to go back to the 
company that provided the incentive in 
the first place’.
He described those attending the 
briefing as ‘directly or indirectly 
represented on the stock exchanges 
of the world’, and appealed to them 
not to let the meeting deteriorate into 
adversity. 
‘I don’t believe any of us can stand 
silently by and watch practitioners 
be sanctioned for taking perverse 
incentives dreamed up north of Sandton 
and find that organisations allow this 
to happen without insisting we look at 
the pharmacos that have devised this 
as well.’
On the other hand, a drug company 
sales rep recently complained to him 
that a doctor was demanding up-front 
payment merely to place an order. ‘He 
told me he was having huge trouble 
getting into the doctor’s surgery 
because his company wouldn’t pay 
to get in – as I scratched the surface 
I discovered a divide between the 
pharmacy side and the medical side 
– that’s why we’re here today.’
Gaping legal holes encourage 
kickbacks
There was consensus between four 
key experts who briefed the meeting 
that gaping regulatory holes and lack 
of definition in Section 18A of the 
Medicines and Substances Control Act 
and delays in promulgating parts of 
the Health Act were among the main 
reasons for continuing perversities and 
harmful business practices.
Val Beaumont, executive director of 
Innovative Medicines of South Africa 
said, ‘the problem is that a (drug 
industry) code of conduct alone will 
not solve the problem faced by the 
HPCSA – the principles need to be 
supported by broader health legislation. 
As an industry we’ve tried to ensure 
alignment across the health sector’.
She said perverse incentives would 
persist as long as there were gaps in 
the legislation or ill-fitting legislative 
attempts to cover things such as the 
recent ‘escalation in a whole lot of 
behaviour that cannot be covered by 
our marketing code’.
She was referring to the publication 
of the drug pricing regulations, which 
she said urgently needed the support of 
further regulations to create transparent 
and capped logistics fees to prevent 
perverse practices.
Beaumont also singled out the 
marketing of complementary medicines 
and medical devices as two areas 
where patients remained at the mercy 
of unrestricted advertising practices. 
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Although the Medicines Amendment 
Bill was meant to address this, ‘the 
process is stalling and it’s a problem’.
Singling out the issue of ‘sampling’ 
as one example of where the act was 
not being properly enforced, she said 
there were several other places where 
the law could be broken. ‘It’s very 
important that the rules are the same 
for all players – not just pharma and the 
medical profession, but hospitals and all 
health establishments as well.’
While the HPCSA had an enforceable 
code, the Pharmacy Council had begun 
‘working in this direction and we hope 
to reach alignment’. She described the 
pharmaceutical code as ‘super’, but said 
it needed the backing of legislation and 
support from the Medicines Control 
Council, the HPCSA and the national 
health department. ‘We need the 
marketing code to be regulated with 
meaningful sanctions and we need 
the regulatory gaps to be closed,’ she 
concluded.
Doctors ‘are real suckers’
Morgan Chetty, Professor of Managed 
Care and Health Services Management 
at the University of KwaZulu-Natal 
and chairperson of the South African 
Managed Care Coalition, said doctors 
were ‘real suckers for this kind of thing’.
‘They’re getting sucked into a system 
where the ethical rules punish them 
for what they do wrong. We’re morally 
obliged to circulate the discussion at this 
meeting to our membership.’ He said 
the issue centred on ‘what doctors do 
because they get paid more (commercial 
versus clinical)’ and how easily greed 
became normative practice.
Chetty cited a medical representative 
from a wholesale company recently 
asking him whether she should make 
out a cheque to him or to him and his 
partner, ‘because their IT company had 
identified our practice as a big user, 
so it calculated our cheque to be this 
much’. When he asked that she supply 
him with ‘clearance from the respective 
ethical houses on reasons why I should 
accept’, she responded in an aggrieved 
tone that no other doctor had responded 
to her in that manner that day.
‘What we’re saying to our doctors 
today is, don’t take that cheque – ever! 
You’ll get into something that you won’t 
be able to get out of. Your colleagues 
will report you and you’ll be made a 
precedent case with the HPCSA.’
Advocate Tshepo Boikanyo, General 
Manager of Legal Services at the 
HPCSA, cited the famous perverse 
incentives case against specialist Percy 
Millar, which they won in spite of 
protracted appeals from an incensed 
Millar who believed he was unfairly 
singled out.
In 2003, the Linksfield neurosurgeon 
was charged with disgraceful conduct 
after receiving kickbacks amounting 
to R765 153 for referring patients from 
Linksfield Clinic to another private 
practice. He proved a guinea pig for the 
HPCSA’s new sanctions.
Chetty said that while the number of 
doctors involved in such practices had 
dropped ‘to a very tiny number’ since 
the HPCSA came into being, the debate 
remained highly relevant.
Asked what kind of sanction could 
be ‘realistically enforced’ on companies 
enticing doctors to accept backhanders, 
Boikanyo said this was dealt with in 
terms of criminal law, where a ‘corrupt 
relationship between a practitioner 
registered with us and somebody who 
is not, is referred to the courts’.
‘Where there’s a corruptee, there’s 
a corrupter,’ he added, recalling ‘from 
memory’ that the stipulated sentence 
was a year in jail or a R12 000 fine or 
both, something an audience member 
quipped could be ‘made up in 10 
minutes of trading’.
Boikanyo said magistrates were 
required by law to refer cases involving 
doctors to the HPCSA, while the 
reverse also applied. He said the 
HPCSA regulations relied on the 
profession of medicine being based on 
a relationship of trust with patients. On 
researching the definition of profession, 
he had discovered that it meant ‘a 
dedication or promise or commitment 
publicly made’.‘That makes it a moral 
enterprise,’ he stressed.
Behrman described the meeting, 
which delegates paid to attend, as a 
‘joint attempt to clean up the act and get 
on with delivery of health care to a very 
large number of South Africans who 
have nothing at present’.
He appealed to his audience to ‘go 
back to your boards and tell them this 
is a Third World country of 45 million 
people. How can we afford to over-
incentivise doctors to utilise medicine 
that is not necessary?’
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